Marekani - Kiingereza - NLM (National Library of Medicine)

physicians total care, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension usp is indicated as follows: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with can

Marekani - Kiingereza - NLM (National Library of Medicine)

rebel distributors corp - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 40 mg in 1 ml - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension, usp is indicated as follows: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia, hypercalcemia associated with c

Marekani - Kiingereza - NLM (National Library of Medicine)

par pharmaceutical, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension is indicated as follows: a llergic states : control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. de rmatologic diseases : bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). e ndocrine disorders : primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalc

Marekani - Kiingereza - NLM (National Library of Medicine)

international nature nutraceuticals - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - methyl salicylate 118.8 mg - for the temporary relief of minor aches and pains of muscles and joints due to: simple backache, arthritis, strains, bruises, strains you are allergic to salicylates or asprin. condition worsens, or if symptoms persist for more than 7 days, or clear up and occur again within a few days. if pregnant or breast-feeding, ask a health professional before use.

Marekani - Kiingereza - NLM (National Library of Medicine)

starman consulting llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - methyl salicylate 20 g in 100 g - pain & muscle relief for the temporary relief of minor aches and pains of muscles and joints. do not use otherwise than as directed. do not use on wounds or broken skin. do not use if known sensitivity to neuromax exists, or if allergic to salicylate or any ingredients of this product stop use and ask a doctor if skin irritation occurs or gets worse, symptoms persist for more than 7 days,  or symptoms clear up and occur within a few days.

Marekani - Kiingereza - NLM (National Library of Medicine)

alexso, inc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - topical analgesic for the temporary relief of minor aches and pains of muscles and joints, such as simple backache, lumbago, arthritis, neuralgia, strains, bruises, and sprains.

Marekani - Kiingereza - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - topical analgesic for the temporary relief of minor aches and pains of muscles and joints, such as simple backache, lumbago, arthritis, neuralgia, strains, bruises, and sprains.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

biotech pharmaceuticals pty ltd - methyl salicylate -

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - methyl salicylate 50%;   - topical ointment - 50 % - active: methyl salicylate 50%   excipient: lanolin white beeswax

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - methyl salicylate 25%{vol};   - liniment - 25% v/v - active: methyl salicylate 25%{vol}   excipient: arachis oil